Abzena secures $65m to expand production capacity, mammalian biologics site set to come online
Abzena, a global CDMO specializing in the integrated development and manufacture of complex biologics and bioconjugates, has secured $65M in new funding.
Archives for March 31, 2022
Biotech pioneer focused venture capital firm exceeds funding target
V-Bio Ventures, a venture capital firm supporting young pioneering biotech companies raises €110m (US$122m) in its second fund, V-Bio Fund 2, exceeding its target of €100m.
ThermoGenesis launches automated cell therapy CDMO
The company will also begin work on creating a cGMP manufacturing facility in Sacramento, California, to house its CDMO division.
Sanofi strikes $6bn antibody collaboration deal
Sanofi and IGM announce partnership to develop IgM antibody agonists against oncology and immunology/inflammation targets.